2022 annual financial data
Zhengye Biotechnology Holding 2022 Revenue growth
Direct answer
Revenue growth was 21.58%.
Operating income was 65,834,000 CNY and net income was 46,735,000 CNY.
Operating cash flow was 17,335,000 CNY.
Get free Zhengye Biotechnology Holding email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 260,269,000 CNY
- Operating income
- 65,834,000 CNY
- Net income
- 46,735,000 CNY
- Operating cash flow
- 17,335,000 CNY
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Zhengye Biotechnology Holding financial years